MSB 11.8% $1.57 mesoblast limited

Cell Therapy News/Articles, page-1998

  1. 268 Posts.
    lightbulb Created with Sketch. 41
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694112/

    But note, now claiming post hoc analysis

    Also not clear how long the patients had had COPD. Fibrotic lung damage that has consolidated and scarred has not been much amenable to treatment AFAIK. Much better to prevent or treat early...


    On a side note https://www.sciencedaily.com/releases/2018/07/180703131423.htm

    Metformin reverses established lung fibrosis

    Diabetes drug a potential therapy for idiopathic pulmonary fibrosis, suggests research with human lung fibroblasts, mouse model of lung fibrosis

    Date: July 3, 2018
    Source: University of Alabama at Birmingham
    Summary:
    Researchers have shown -- for the first time -- that established lung fibrosis can be reversed using a drug treatment that targets cell metabolism. The finding is important because, despite significant advances to reveal the pathological mechanisms of persistent fibrosis, effective treatment interventions are lacking.

    ...
    Using a mouse model for lung fibrosis elicited by the anti-cancer drug bleomycin, the research team found metformin treatment, starting three weeks after lung injury and continuing for five weeks, accelerated the resolution of well-established fibrosis. Such resolution was not apparent in AMPK-knockout mice, showing that the effect of metformin was AMPK-dependent.
    ...
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.57
Change
-0.210(11.8%)
Mkt cap ! $1.792B
Open High Low Value Volume
$1.72 $1.74 $1.52 $15.63M 9.716M

Buyers (Bids)

No. Vol. Price($)
1 5127 $1.57
 

Sellers (Offers)

Price($) Vol. No.
$1.57 39613 3
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.